Imagenetix Inc.
10845 Rancho Bernardo Road
Suite 105
San Diego,
CA 92127
United States - Map
Phone: 858-674-8455
Fax: 858-674-8460
Web Site: http://www.imagenetix.net
| Imagenetix, Inc. develops and formulates propriety over-the-counter topical creams, skincare products, and nutritional supplements. Its primary product is Celadrin, a nutritional supplement compound comprised of fatty acid esters that play a role in human and animal joint health; other formulations, including an oral product, a cream, and a pet product; and natural based products for specific health issues, including compounds and formulations. The company also develops therapies for the treatment of inflammatory conditions, such as periodontal disease. In addition, it involves in in-vivo and in-vitro efficacy and safety studies on its drug compound for the treatment of gum disease, including periodontitis. Further, the company develops and sells products and formulations for businesses and organizations. It markets its products through various channels of distribution, including direct/network/multi-level marketing companies, chain store retailers, medical newsletters, and direct response radio and television, as well as medical, health, and nutritional professionals. Imagenetix, Inc. was founded in 1996 and is based in San Diego, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. William P. Spencer , 57
Chief Exec. Officer, Pres, Director and Member of Audit Committee |
N/A
| N/A | Mrs. Debra L. Spencer , 57
Sec., Treasurer |
$
97.00K | N/A | Mr. Lowell W. Giffhorn , 62
Chief Financial Officer and Principal Accounting Officer |
N/A
| N/A | Mr. Derek C. Boosey , 66
VP of International |
N/A
| N/A | Dr. Robert L. Hesslink Jr., Sc.D.,
Director of R&D and Member of Scientific and Medical Advisory Board |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.22% Nasdaq 
Profile
